[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![PrismMarketView Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1257318598386696195.png) PRISM MarketView [@PrismMarketView](/creator/twitter/PrismMarketView) on x 4675 followers
Created: 2025-07-18 15:56:14 UTC

$SRPT
@Sarepta Therapeutics shares tumble following a third reported patient death linked to its gene therapy program, sparking renewed safety concerns. The company faces growing scrutiny as it defends the treatment's benefit-risk profile.



XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946237583941365806/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$srpt](/topic/$srpt)
[prism](/topic/prism)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/PrismMarketView/status/1946237583941365806)